- The FDA has approved a first-of-its-kind blood test for colon-cancer screening.
- While the test has been available since 2022, the approval could make it more accessible.
- Colorectal-cancer cases and deaths are increasing in younger people. Early treatment is crucial.
The Food and Drug Administration has approved a blood test as a primary screening tool for colorectal cancer, opening the door for more people to get tested without paying hundreds of dollars out of pocket.